Immune-related Encephalitis in Two Patients Treated With Immune Checkpoint Inhibitor

Clin Lung Cancer. 2020 Sep;21(5):e474-e477. doi: 10.1016/j.cllc.2020.03.006. Epub 2020 Mar 20.

¹ Respiratory Medicine Department, CHU Rennes, Rennes, France; CLCC Eugène Marquis, Service d'oncologie médicale, Rennes, France.
² Neurology Department, CHU Rennes, Rennes, France.
³ Respiratory Medicine Department, CHU Rennes, Rennes, France.
⁴ Respiratory Medicine Department, CH Saint-Malo, Saint-Malo, France.
⁵ Respiratory Medicine Department, CHU Rennes, Rennes, France; INSERM U1242, Chemistry Oncogenesis Stress and Signaling, CLCC Eugène Marquis, Rennes, France.
⁶ Respiratory Medicine Department, CHU Rennes, Rennes, France; INSERM U1242, Chemistry Oncogenesis Stress and Signaling, CLCC Eugène Marquis, Rennes, France. Electronic address: charles.ricordel@chu-rennes.fr.

No abstract available

Keywords: Atezolizumab; Immune encephalitis; Immune-related adverse events; NSCLC; Nivolumab.

Publication types